Developing Broad-Spectrum Antivirals Using Porcine and Rhesus Macaque Models.
ISG15-deficient humans exhibit permanent, low-level expression of antiviral effectors that safely protect them from various viruses. Since the murine ISG15 axis functions differently, we identified animal models that recapitulate the human condition for the development of ISG15-targeting broad-spectrum antivirals. Canine, porcine, and rhesus macaque ISG15, like human ISG15, stabilize USP18, a potent inhibitor of IFN-I. IFN-primed ISG15-knockout porcine and rhesus cells demonstrate enhanced ISG expression and protection against VSV infection compared to WT. Collectively, we unveil the interspecies diversity of the ability of ISG15/USP18 axis to control IFN-I signaling and reveal the therapeutic potential of ISG15-deficient porcine and rhesus models.